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ABSTRACT 
 
Zachary G. Robbins 
 
DETERMINATION OF ALIPHATIC AMINES IN URINE AS BIOMARKERS OF 
EXPOSURE TO 1,6-HEXAMETHYLENE DIISOCYANATE AND ISOCYANURATE 
(Under the direction of Dr. Leena A. Nylander-French) 
 
Biological monitoring of 1,6-hexamethylene diisocyanate (HDI) exposure has been 
limited to the hydrolysis product of HDI monomer.  The determination of acetylated 1,6-
diaminohexane (HDA) and isotriamine as biomarkers of HDI and isocyanurate exposure, 
respectively, can provide important insight into the metabolism and dose-response 
relationships of these compounds. The objective of this study was to develop a liquid 
chromatography-mass spectrometry (LC-MS) method to detect HDA, monoacetyl-HDA, 
diacetyl-HDA, and isotriamine in urine. The LC-MS method was developed using the four 
standards spiked into urine at concentrations between 0.019-10.144 µg/L. Quantification of 
serial dilutions of the standards in urine was performed using selected reaction monitoring on 
a triple quadrupole mass spectrometer. The limit of detection and the limit of quantification 
in spiked urine were 0.01 and 0.02 µg/L for monoacetyl-HDA, respectively, and 0.16 and 
0.31 µg/L for diacetyl-HDA, respectively. HDA and isotriamine were not detectable in urine 
at concentrations below 10 µg/L because of high background level of other unspecified 
compounds. The developed LC-MS method is sensitive and specific for the quantification of 
acetylated metabolites of HDI. However, modifications to the method are necessary to 
improve the specificity and sensitivity of HDA and isotriamine analyses.
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CHAPTER I 
 
INTRODUCTION 
 
 
Background 
 Isocyanates are low molecular weight aromatic or aliphatic compounds characterized 
by a highly reactive –N=C=O group. They are used in the production of polyurethane 
products such as spray paints, sealants, polyurethane foams, insulation, adhesives, resins, and 
surface coatings (NIOSH 1996; Streicher et al. 1998; Weber 2004). It is estimated that over 3 
billion pounds of isocyanates are produced yearly worldwide (Woods 1987). In 1995 the 
National Institute for Occupational Safety and Health (NIOSH) estimated that approximately 
280,000 U.S. workers were exposed to isocyanates (NIOSH 1996). The most commonly used 
diisocyanates are hexamethylene diisocyanate (HDI), toluene diisocyanate (TDI), and 
methylene diphenyl diisocyanate (MDI). Diisocyanates are characterized by having two 
isocyanate groups (–N=C=O) and react readily with water, nucleophiles, or with themselves 
to form dimers and trimers (Liu et al. 2000; NIOSH 1996). 
In the automotive refinishing industry, most frequently used paints and clear coats 
contain small amounts of HDI (<1%) and much higher amounts of HDI oligomers uretdione, 
biuret, and isocyanurate. Figure 1 shows the chemical structure of the four isocyanates 
commonly present in HDI-based paints and clear coats. The most abundant oligomer in HDI-
based paints and clear coats is isocyanurate (Rosenberg et al. 1984; Pronk et al. 2006; Fent et 
al. 2008; Fent et al. 2009a; Fent et al. 2009b).
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Figure 1. Chemical structures of the four isocyanates (HDI, uretdione, biuret, and 
isocyanurate) present in HDI-based paints and clear coats. 
 
Health Effects 
Isocyanate exposure poses acute and chronic health risks to the respiratory system 
and to the skin (Bernstein 1996). Health effects of isocyanate exposure include rhinitis, 
irritation of the skin, eyes, and mucous membranes, as well as allergic contact dermatitis and 
hypersentivity pneumonitis (NIOSH 1978; NIOSH 2005; Goossens et al. 2002). Isocyanates 
are the leading cause of occupational asthma in workers exposed through the inhalation and 
dermal routes (reviewed in Bello et al. 2007). Isocyanate-induced asthma is typically a result 
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of repeated exposure during which sensitization occurs. After sensitization, even a low level 
of isocyanate inhalation exposure can induce asthmatic response (reviewed in Bello et al. 
2007). More recently, it has been postulated that an asthma attack can be induced through 
dermal exposure of isocyanates (Rattray et al. 1994; reviewed in Bello et al. 2007). 
 
Biological Monitoring of HDI Exposure 
 Exposure assessment of HDI concentrations in spray painters’ breathing zones and 
skin has been previously conducted and shown measurable levels of HDI (Maitre et al. 1996; 
Pronk et al. 2006; Fent et al. 2008; Fent et al. 2009a; Fent et al. 2009b). However, biological 
monitoring of HDI exposure in occupationally exposed workers has been limited to 1,6-
diaminohexane (HDA), the hydrolysis product of HDI (Tinnerberg et al. 1995; Maitre et al. 
1996; Pronk et al. 2006). The known HDI metabolites in blood and urine are aliphatic 
carbon-chain amines, which include HDA, monoacetyl-HDA, and diacetyl-HDA (Flack et al. 
2010b). The chemical structures of these compounds are presented in Figure 2. 
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Figure 2. The chemical structures of HDI metabolites. 
 
Historically, HDA is the only metabolite used as a biomarker of HDI exposure in 
urine and blood (Tinnerberg et al. 1995; Maitre et al. 1996). Acetylated forms of HDA have 
not been monitored because acid hydrolysis, the most commonly used sample work-up 
method, converts monoacetyl-HDA and diacetyl-HDA back to HDA. HDA detected in urine 
resulting from HDI exposure could actually represent a mixture of the three metabolites (i.e., 
HDA, monoacetyl-HDA, and diacetyl-HDA). Any variability in individual metabolite 
formation is masked by acid hydrolysis. This leaves an important gap in characterizing the 
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individual metabolic differences that may be relevant in the development of hypersensitivity 
and asthma. 
As shown in the proposed metabolic pathway for HDI exposure below in Figure 4 
(Flack et al. 2010b), HDI can be hydrolysed to HDA (5) or it can form intermediate products 
that break down to HDA. HDA (5) can form protein adducts via CYP450/FMO (8, 9, 3A) or 
monoacetyl-HDA through N-acetyltransferase (NAT) activity (6) (Maitre et al. 1996; 
Wikman et al. 2002). Monoacetyl-HDA can form diacetyl-HDA through NAT (7) which is 
eliminated in urine, or oxidize via CYP450/FMO (8, 9, 3A) to form protein adducts. Genetic 
variations of the NAT1 enzyme can result in slow or fast N-acetylation (Wikman et al. 2002). 
Fast acetylation of HDA would result in higher levels of diacetyl-HDA eliminated in urine 
while slow acetylation would result in higher amount of free or protein-bound monoacetyl-
HDA (3A). The differences in acetylator phenotype can be monitored via alkaline hydrolysis 
through the variable levels of free diacetyl-HDA (7) and adducted monoacetyl-HDA 
compared to total HDA concentration via acid hydrolysis. Individuals with a slow acetylator 
phenotype would likely form more HDA protein adducts. Previous studies have shown that 
exposed workers with the NAT1 slow acetylator status had a 2.5-fold risk of developing 
diisocyanate-induced asthma (Wikman et al. 2002) as well as having lower amounts of 
monoacetyl-HDA in urine (Brorson et al. 1990a). 
Studies have focused on biological monitoring of HDI exposure through HDA 
measurements in blood and urine. However, it has been shown that isocyanurate (HDI 
oligomer) is the most abundant isocyanate in HDI-based paints and clear coats (Rosenberg et 
al. 1984; Pronk et al. 2006; Fent et al. 2009a; Fent et al. 2009b). HDI, uretdione, and biuret 
are present in much smaller amounts (Rosenberg et al. 1984; Pronk et al. 2006; Fent et al. 
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2009a; Fent et al. 2009b). Although HDI exposure has been studied, biological monitoring of 
isocyanurate exposure has not been previously addressed. Isotriamine, as shown in Figure 3, 
is the hydrolysis product of isocyanurate and could prove to be a suitable biomarker for 
isocyanurate exposure. 
 
Figure 3. Chemical structure of isotriamine. MW = 426.5 amu. 
 
Therefore, we should expand current efforts to characterize isocyanurate exposure and to 
determine its metabolite(s) that can be used for biomarker analysis. Liu et al. (2004) 
demonstrated that the correlation between exposure to the oligomer biuret and urinary HDA 
was weak. This is an indication that isocyanurate exposure may not correlate with urinary 
HDA levels. New biological monitoring techniques should be developed to determine levels 
of isocyanurate amines in the body in order to clarify the pathways for isocyanurate 
metabolism and to investigate the relationship between inhalation and dermal exposure and 
internal dose received. 
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Figure 4. Proposed HDI metabolic pathways. Diagram shows the enzymatic (GST, 
NAT, CYP450) and non-enzymatic directed HDI metabolic pathways leading to 
formation of HDI-protein adducts, potential immune response, and elimination (Flack 
et al. 2010b). 
 
Analysis of Isocyanate Biomarkers 
 In the past few decades, many analytical methods have been developed for the 
analysis of free amines of diisocyanates in urine and blood samples collected from exposed 
workers. The majority of these methods utilize gas chromatography-mass spectrometry (GC-
MS). Rosenberg et al. (1986) developed a method for a measurement of HDA in urine that 
  8 
has since been widely used and modified. Determination of urinary HDA typically involves 
acidic hydrolysis and derivatization with a fluorinated anhydride and analysis of the 
fluorinated derivatives using GC-MS (Rosenberg et al. 1986; Brorson et al. 1990a; Dalene et 
al. 1994; Tinnerberg et al. 1995). The procedure calls for acid hydrolysis of urine with 
sulfuric acid with heat for 4-16 h, followed by adjustment to basic pH with sodium hydroxide 
and sodium chloride. HDA is extracted from urine using an organic solvent such as toluene, 
ethyl acetate, diethyl ether, or dichloromethane. The organic extract is dried over anhydrous 
sodium sulfate. The sample is derivatized using a fluorinated anhydride such as 
heptafluorobutyric anhydride (HFBA) or pentafluoroproprionic anhydride (PFPA) with heat. 
Sample is then dried under nitrogen and reconstituted in ethyl acetate or toluene. The 
reconstituted sample is analyzed by GC-MS. Similar methods have been developed for the 
work-up and GC-MS analysis of TDA derivatives (Rosenberg et al. 2002; Sennbro et al. 
2003; Marand et al. 2004) and MDA derivatives (Rosenberg et al. 2002; Sennbro et al. 2003; 
Sennbro et al. 2006). 
Biomarkers of HDI exposure in urine and blood samples of occupationally exposed 
workers have been characterized in previous studies using acid hydrolysis and GC-MS 
analysis (Maitre et al. 1996, Flack et al. 2010ab; Gaines et al. 2010). Total HDA has been 
characterized in acid-hydrolyzed urine and blood plasma as a biomarker for short-term 
(Tinnerberg et al. 1995; Maitre et al. 1996; Gaines et al. 2010) and cumulative (Flack et al. 
2010b) exposure to HDI monomer. The key constraint of acid hydrolysis of urine and plasma 
is that measured HDA can represent a combination of free HDA and HDA conjugated to 
proteins or macromolecules, free monoacetyl-HDA and monoacetyl-HDA conjugated to 
proteins or macromolecules, and free diacetyl-HDA. Acid hydrolysis converts acetyl groups 
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on monoacetyl-HDA and diacetyl-HDA back to HDA and also releases bound HDA and 
monoacetyl-HDA from proteins or other macromolecules. It is not possible to differentiate 
between the different forms of HDA present and whether they are free or bound to 
macromolecules.  Thus, acid hydrolysis can mask the individual variability associated with 
HDA metabolism and protein adduct formation. 
 Alkaline hydrolysis has been used for MDA biomarker analysis in urine, plasma, and 
hemoglobin (Sepai et al. 1995a; Sepai et al. 1995b; Sennbro et al. 2003), TDA biomarkers in 
plasma (Sennbro et al. 2003), and more recently for HDA analysis in urine (Dalene et al. 
1994; Flack et al. 2010b). This method releases acetylated amines from proteins without 
converting the acetyl functional groups back to the original amine form. The ability to 
determine levels of HDA and its acetylated forms allows for better understanding of 
metabolism and elimination of HDI. However, in only a few studies has alkaline hydrolysis 
been utilized to analyze acetylated biomarkers in urine and/or blood. 
 HDA has primarily been analyzed as a fluorinated derivative using GC-MS (Brorson 
et al. 1990a; Tinnerberg et al. 1995; Flack et al. 2010ab; Gaines et al. 2010). An advantage of 
GC-MS analysis is high sensitivity with a low limit of detection (LOD) for HDA-HFBA 
derivatives (Liu et al. 2004; Flack et al. 2010ab; Gaines et al. 2010).  However, the extraction 
and derivatization process introduces sample loss through inefficiency of extraction and 
volatility of HFBA derivatives. Sakai et al. (2002) reported extraction efficiencies for 
common solvents used in studies investigating TDA isomers. The highest reported efficiency 
was 76.2% for dichloromethane while toluene and ethyl acetate, more commonly used 
solvents, had extraction efficiencies of 27.1% and 52.0%, respectively (Sakai et al. 2002). 
Solvent extraction and the additional steps of derivatization and drying under nitrogen allow 
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for significant sample loss that is not desirable for analysis of trace amounts of compounds in 
a biological media. 
Liquid chromatography-mass spectrometry (LC-MS) has been used less frequently 
for biomarker analysis of isocyanate exposure compared to GC-MS analysis. LC-MS 
analysis has been used previously for HDA derivatives (Skarping et al. 1994a; Tinnerberg et 
al. 1995) and for derivatives for MDA (Skarping et al. 1994b), IPDA (Tinnerberg et al. 
1995), and TDA (Marand et al. 2004). As mentioned previously, extraction and 
derivatization of samples can result in significant sample loss. It would be advantageous to 
reduce sample loss by eliminating the need to extract and derivatize a biological sample. This 
could be achieved by analyzing the free amine form using LC-MS. Sakai et al. (2002) 
successfully monitored TDA isomers using LC-MS with positive electrospray ionization. To 
date, there is no published method for analysis of HDA, monoacetyl-HDA, diacetyl-HDA, or 
isotriamine by LC-MS without the requirement of derivatization. Analysis of isotriamine 
necessitates the use of LC-MS because isotriamine derivatives are too large for GC-MS 
analysis (>1000 amu). Also, the elimination of extraction and derivatization steps would 
increase our ability to detect the metabolites in workers with low exposures to HDI and 
isocyanurate. An LC-MS method could be more sensitive than a GC-MS method for 
detection of HDI metabolites in biological media while simultaneously allowing for the 
detection of metabolites of isocyanurate. 
I report here an LC-MS method for the determination of monoacetyl-HDA and 
diacetyl-HDA in urine that does not require any extraction or derivatization. This method is 
sensitive and specific for these compounds and expands upon previously published methods 
(Tinnerberg et al. 1995; Maitre et al. 1996, Flack et al. 2010ab; Gaines et al. 2010) to include 
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the analysis of HDA, monoacetyl-HDA, diacetyl-HDA, and isotriamine. Additionally, this 
method significantly reduces time for sample work-up and analysis as well as sample loss 
because extraction and derivatization steps have been eliminated in sample processing.
CHAPTER II 
 
MATERIALS & METHODS 
 
 
Chemicals 
Ethyl acetate (>99.5%), glacial acetic acid, sodium sulfate anhydrous, and sodium 
hydroxide (ACS grade) were purchased from Fisher Scientific (Hampton, NH) and were used 
as received. Acetic anhydride (>99%), 1,6-hexanediamine (HDA, 99.5+%) and 1,7-
diaminoheptane (HpDA; 98%) were purchased from Acros Organics (Geel, Belgium).  
Dichloromethane (HPLC grade >99.9%), hydrochloric acid (37%), ether (ACS grade), 
triethylamine, formic acid (98% and 85%), magnesium sulfate (MgSO4), and                  
N,N’-hexamethylene-bisacetamide (diacetyl-HDA; 98%) were obtained from Sigma-Aldrich 
(St. Louis, MO). Ammonium hydroxide was obtained from E. Merck Industries (Darmstadt, 
Germany). Acetonitrile (HPLC grade, >99.8%) and methanol (HPLC grade, >99.9%) were 
purchased from Mallinckrodt Chemicals (Phillipsburg, NJ). Desmodur 3300 (HDI monomer 
and oligomers) was received from Bayer AG (Leverkusen, Germany). 
 
Instrumental Analysis 
 Nuclear magnetic resonance and mass spectrometric analysis (NMR) was performed 
on a Varian Inova NMR spectrometer (Agilent Technologies, (Santa Clara, CA) operating at 
400 MHz for 1H NMR and at 100 MHz for 13C NMR.
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Initial LC-MS method development was performed with a Thermo Finnigan Surveyor 
high-performance liquid chromatograph (HPLC); coupled to a Thermo Finnigan LCQ DECA 
ion-trap mass spectrometer (Waltham, MA). Reversed phase separations were carried out 
using a Hypersil GOLD aQTM 3 µm, 2.1 x 150 mm column (Thermo Scientific, Waltham, 
MA). Samples (15 µL) were injected and eluted at a flow rate of 250 µL/min using the 
gradient program shown below (Table 1), where solvent A is 0.1% formic acid in DI-H2O 
and solvent B is 50:50 acetonitrile:methanol. 
 
Table 1. Gradient program for the HPLC ion-trap method. 
Time (min) % A % B Flow Rate (µL/min) 
0.00 95 5 250 
2.00 95 5 250 
9.00 10 90 250 
14.00 10 90 250 
16.00 95 5 250 
20.00 95 5 250 
 
The same gradient program was used for discovery and method development for all analytes. 
Analytes were ionized in an electrospray ionization source operated in the positive-ion mode 
(ESI+) and detected by full-scan (50-600 m/z) mode and selected ion monitoring (SIM) mode 
by monitoring the [M+H]+ ions. The major ions monitored [M+H]+ were m/z=117 (for 
HDA), m/z=131 (for HpDA), m/z=159 (for monoacetyl-HDA), m/z=173 (for monoacetyl-
HpDA), m/z=201 (for diacetyl-HDA), m/z=215 (for diacetyl-HpDA), and m/z=427 (for 
isotriamine). 
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LC-MS analysis for calibration curves was performed on a Thermo Scientific Accela 
ultra-performance liquid chromatography (UPLC); coupled to a Thermo Finnigan Quantum 
triple quadrupole mass spectrometer (Waltham, MA). Reversed phase separations were 
carried out using a Hypersil GOLD aQTM 1.9 µm, 2.1 x 100 mm column (Thermo Scientific, 
Waltham, MA). Samples (25 µL) were injected and at a flow rate of 250 µL/min using the 
following gradient program shown below (Table 2), where solvent A is 0.1% formic acid in 
DI-H2O and solvent B is 50:50 acetonitrile:methanol. 
 
Table 2. Gradient program for the UPLC-triple quadrupole method. 
Time (min) % A % B Flow Rate (µL/min) 
0.00 98 2 250 
2.00 98 2 250 
9.00 10 90 250 
12.00 10 90 250 
13.00 98 2 250 
16.00 98 2 250 
 
Analytes were ionized using an electrospray ionization operated in the positive-ion 
mode (ESI+) and detected in the SRM mode by monitoring [M+H]+ → [M + H – NH3]+ for 
HDA and HpDA, [M+H]+ → [M + H – acetate]+  for monoacetyl-HDA and monoacetyl-
HpDA, [M+H]+ → [M + H – ketene]+ for diacetyl-HDA and diacetyl-HpDA and [M+H]+ → 
isocyanuric acid for isotriamine. Parameters for each analyte were optimized by loop 
injection. Table 3 shows the major parent ions [M+H]+ and corresponding product ions with 
the optimal tube lens setting and collision energy for each product ion. 
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Table 3. Selected reaction monitoring method for the UPLC triple quadrupole. Data 
was obtained with direct injections into the mass spectrometer. Only the second most 
abundant product ions for monoacetyl-HDA and diacetyl-HDA are listed because they 
were used in the method for obtaining calibration curves. 
 
Parent 
Ion 
(m/z) 
Product Ion 
(most 
abundant) 
(m/z) 
Collision 
Energy (v) 
Product Ion 
(2nd most 
abundant) 
(m/z) 
Collision 
Energy 
(v) 
Tube 
Lens 
HDA 117.10 100.20 10   121.88 
HpDA 131.10 114.20 11   119.88 
Monoacetyl-HDA 159.00 100.20 15 142.19 13 125.39 
Monoacetyl-
HpDA 173.10 114.21 16   131.39 
Diacetyl-HDA 201.10 159.18 14 100.18 20 148.16 
Diacetyl-HpDA 215.20 173.19 16   132.89 
Isotriamine 427.50 130.02 35   129.14 
 
Thermo Finnigan Xcalibur software generated the chromatograms and mass spectra 
for the samples analyzed with the ion trap and the triple quadrupole mass spectrometers. 
Peaks were integrated using the interactive chemical information system (ICIS) application 
within Xcalibur and manual adjustments were performed as needed. Calibration curves were 
generated using Microsoft Excel as a ratio of standard peak areas to internal standard peak 
areas (HDA/HpDA; monoacetyl-HDA/monoacetyl-HpDA; diacetyl-HDA/diacetyl-HpDA). 
The standard curve for isotriamine was calculated using the peak area because we did not 
have an internal standard. 
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Preparation of Diacetyl-HpDA 
 HpDA (2.6 g, 20 mmol) was dissolved in ethyl acetate (50 mL), and pyridine (10 mL) 
added followed by acetic anhydride (6 mL) at 0°C dropwise. The mixture was brought to 
room temperature and stirred for 1 h. The precipitate was filtered and washed with ethyl 
acetate to obtain diacetyl-HpDA as a white solid. 
 
Preparation of Monoacetyl-HDA and Monoacetyl-HpDA 
  HDA or HpDA (20 mmol) was dissolved in acetic acid (50 mL) and heated to 60°C 
to get homogenous solution. After cooling to room temperature, a solution of acetic 
anhydride (1 mL) in 10 mL of acetic acid was added dropwise and the mixture was stirred at 
ambient temperature overnight. After removing the bulk of the solvent using a rotary 
evaporator, the residue was dissolved in water (50 mL) and HCl (37% 2 mL) and washed 
with ethyl ether to remove any diacetylated side product. The aqueous layer was basified 
with aqueous NaOH and extracted with ether. The organic layer was dried over MgSO4 and 
concentrated. The residue was purified by chromatography (dichloromethane/methanol/ 
ammonium hydroxide) to obtain the desired product as viscous liquid at room temperature. 
 
Preparation of Isotriamine 
 Desmodur 3300 (1 g) was added to 6N HCl (20 mL) and the mixture was heated to 
reflux for 30 min. After cooling to room temperature, the reaction mixture was extracted with 
ethyl ether (2 x 20 mL) and the aqueous layer was concentrated on  a rotary evaporator to 
obtain the salt as white solid. To purify the product the salt was dissolved in water and made 
basic with the addition of 100 mL ammonium hydroxide. Isotriamine was extracted from the 
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solution using dichloromethane (3 x 2.5 mL), then centrifuged and freeze/thawed for better 
separation. The extract was dried under nitrogen, weighed, and dissolved in water to get a 1 
mg/mL solution which was stored as a stock solution at 4°C.  
 
Development of Standard Curves in Spiked Urine 
Stock solutions of commercially available HDA, HpDA, and diacetyl-HDA as well as 
synthesized monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HpDA, and isotriamine (each 5 
mg/mL) were made by dissolving 12.5 mg of the amine in 5 mL water (2.5 mg/mL) and the 
solutions were acidified by the addition of 5 µL formic acid (0.1%). The stock solutions were 
then diluted to 100 µg/mL by adding 80 µL of stock solution to 1.92 mL water. Solutions 
were diluted further to 10 µg/mL by adding 100 µL of 100 µg/mL solution of each standard 
to 1.9 mL water. The standards HDA, monoacetyl-HDA, diacetyl-HDA, and isotriamine 
were diluted to 1 µg/mL by adding 100 µL of 10 µg/mL solution to 1.9 mL water. The 
internal standards HpDA, monoacetyl-HpDA, and diacetyl-HpDA were diluted to 500 µg/L 
by adding 50 µL of 10 µg/mL solution of each internal standard to 1.9 mL water. These 500 
µg/L internal standard solutions were further diluted to 125 µg/L by adding 500 µL of 500 
µg/L solution of each internal standard to 1.5 mL water. 
 The spiked urine work-up procedure was modified from the published methodfor the 
analysis of HDA in urine (Sepai et al. 1995; Flack et al. 2010b). Control urine samples (1 
mL) collected from two individuals with no known HDI exposure were used for the serial 
dilutions. Serial dilutions of spiked the urine samples were performed to obtain the following 
HDA, monoacetyl-HDA, diacetyl-HDA, and isotriamine concentrations: 41.322, 20.492, 
10.144, 5.038, 2.507, 1.247, 0.621, 0.309, 0.154, 0.076, 0.038, 0.019, and 0.0094 µg/L. 
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Initially, 50 µL of each 1 µg/mL standard was added to 800 µL of urine. Formic acid (5 µL) 
was added to ensure the solution (49.5 µg/L) was acidic and then solution was vortexed. The 
solution (500 µL) was diluted 1:1 by adding 500 µL of the solution to 500 µL of control 
urine and 5 µL of formic acid. After the 500 µL was removed from the initial 49.5 µg/L 
solution, 50 µL of each 125 µg/L internal standard was added to obtain a concentration of 
41.322 µg/L. The concentration for each internal standard was 8.26 µg/L. This dilution was 
performed 13 times to obtain concentrations: 41.322, 20.492, 10.144, 5.038, 2.507, 1.247, 
0.621, 0.309, 0.154, 0.076, 0.038, 0.019, and 0.0094 µg/L for HDA, monoacetyl-HDA, 
diacetyl-HDA, and isotriamine. The samples were centrifuged for 45 min at 14000 G using 
an Amicon centrifugal mass filter (3000 Da; Amicon, (Houston, TX). This filter collects 
compounds with a mass greater than 3000 Da, which removes most urinary proteins and 
other macromolecules. The filtrate (<3000 Da) was transferred to a vial for LC-MS analysis. 
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CHAPTER III 
 
RESULTS 
 
 
Chemical Synthesis 
 
 The standards monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HpDA, and 
isotriamine were not commercially available. They were synthesized and characterized by 
proton and carbon nuclear magnetic resonance (1H NMR, 13C NMR). The NMR spectra of 
the synthesized standards monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HpDA, and 
isotriamine are presented in Figures 5 – 8. The 1H NMR spectra confirm the purity of the 
synthesized compounds. LC-MS analysis was performed to obtain the mass spectra of the 
synthesized standards monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HpDA, and 
isotriamine. Figure 9 indicates a base peak of a protonated standard [M+H]+ with a minor 
base peak of the sodium adduct [M+Na]+. 
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Figure 5. 1H NMR and 13C NMR spectra for monoacetyl-HDA. 
 
Figure 6. 1H NMR and 13C NMR spectra for monoacetyl-HpDA. 
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Figure 7. 1H NMR and 13C NMR spectra for diacetyl-HpDA. 
 
Figure 8. 1H NMR and 13C NMR spectra for isotriamine. 
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LC-MS Analysis of Standards 
 The four analytes (HDA, monoacetyl-HDA, diacetyl-HDA, isotriamine) and three 
internal standards (HpDA, monoacetyl-HpDA, diacetyl-HpDA) were mixed together in urine 
to obtain a concentration of 10 µg/mL for each compound in the mixture. This sample was 
analyzed using the procedure, described above for the HPLC-ion trap protocol, to develop 
the optimal solvent mixture and chromatographic parameters for the analytes HDA, 
monoacetyl-HDA, diacetyl-HDA, and isotriamine. Figures 9 and 10 display the mass 
spectrum and respective chromatogram for each compound. 
 
 
Figure 9. Mass spectra from LC-MS analysis of the target analytes and internal 
standards (HDA, HpDA, monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HDA, diacetyl-
HpDA, isotriamine) in a urine sample. The concentration of each compound was 10 
µg/mL. 
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Figure 10. Chromatograms of parent ions of the target analytes and internal standards 
(HDA, HpDA, monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HDA, diacetyl-HpDA, 
isotriamine) in a urine sample using HPLC-ion trap analysis in SIM mode. The 
concentration of each compound was 10 µg/mL. 
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Standard Curves Using LCQ DECA Ion Trap Mass Spectrometer 
 Standard curves were generated to quantify the concentrations of HDA, monoacetyl-
HDA, diacetyl-HDA, and isotriamine in urine. The standard curves were obtained by 
analyzing a set of serial dilutions. In the early stages of the method development, the first 
calibration curves were run with the series of 16 dilutions of the analytes using HPLC 
coupled with the LCQ DECA ion trap mass spectrometer. Points on the curve represented a 
ratio of the analyte peak area to the internal standard peak area (i.e., HDA/HpDA; 
monoacetyl-HDA/monoacetyl-HpDA; diacetyl-HDA/diacetyl-HpDA) with respect to analyte 
concentration. Peak area of isotriamine was used at this time because an internal standard had 
not yet been synthesized. Monoacetyl-HDA and diacetyl-HDA demonstrated linearity but the 
linearity of the standards only included the highest concentrations. Below 10 µg/L, the area 
ratios were scattered around the lines, which may have resulted from pipetting errors or a 
lack of sensitivity in the ion trap. The correlation coefficient (R2) for monoacetyl-HDA and 
diacetyl-HDA ranged from 0.85-0.95 depending on how many concentration points were 
excluded. 
 HDA and isotriamine could be detected at only the 3 highest concentrations using 
either the available Xcalibur integration software or by manual integration. Therefore, a 
calibration curve could not be generated. Due to the lack of sensitivity for HDA and 
isotriamine and an inability to generate linear calibration curves with R2 > 0.99 for 
monoacetyl-HDA and diacetyl-HDA by ion-trap analysis, the protocol was adapted for use 
with a UPLC-triple quadrupole mass spectrometer. 
 
 
   25 
 
Standard Curves Using TSQ Quantum Triple Quadrupole Mass Spectrometer 
 The serial dilutions discussed in the previous section were repeated for analysis on 
the Thermo Finnigan Accela UPLC coupled to a Thermo Finnigan TSQ Quantum triple 
quadrupole mass spectrometer with an electrospray ionization source operated in the positive 
ion mode. The triple quadrupole allowed for increased sensitivity due to the ability of the 
first quadrupole to filter a specific mass and the third quadrupole to detect fragments of the 
filtered masses. The second quadrupole is the collision cell where parent ions are fragmented. 
The mass spectrometer was run in selective reaction monitoring mode (SRM), to monitor 
fragmentation of the protonated parent ion to the most abundant product ion for each of the 
standards and internal standards. 
 Initially test samples containing high concentrations of all seven analytes (i.e., HDA, 
HpDA, monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HDA, diacetyl-HpDA, isotriamine) 
were injected in order  to optimize the chromatographic separation and also to investigate 
sensitivity of the triple quadrupole mass spectrometer to HDA and isotriamine.  The 
standards were added to urine (2 µg/mL each) and analyzed with LC-MS. Figure 11 displays 
the chromatogram of all seven analytes in urine. The acetylated compounds were easily 
distinguishable but, under these conditions, there was no prominent peak present for HDA 
and isotriamine. These test samples were repeated multiple times, but only high 
concentrations in individual samples of HDA and isotriamine were detected using the triple 
quadrupole mass spectrometer. At this point, the LC-MS method does not detect ions of 
HDA and isotriamine at concentrations below 10 µg/L. 
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Figure 11. Chromatograms of the product ions of all the target analytes and internal 
standards (HDA, HpDA, monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HDA, diacetyl-
HpDA, isotriamine) in a urine sample. Chromatogram was obtained with the UPLC-
triple quadrupole mass spectrometer. The injection volume was 25 µL and the 
concentration of each sample was 2 µg/mL. 
 
The rest of the analysis focused on creating calibration curves for monoacetyl-HDA 
and diacetyl-HDA in spiked urine. Figure 12 displays a chromatogram of the monoacetyl-
HDA and diacetyl-HDA standards with the SRM method. Monoacetyl-HDA and diacetyl-
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HDA were analyzed for the two most abundant product ions to enhance the ability to detect 
these compounds at low concentrations. 
 
 
Figure 12. Chromatograms obtained in the SRM mode for monoacetyl-HDA, 
monoacetyl-HpDA, diacetyl-HDA, and diacetyl-HpDA in a urine sample using the 
UPLC-triple quadrupole mass spectrometer. The reactions are indicated on the 
chromatograms. The injection volume was 25 µL. The monoacetyl-HDA and diacetyl-
HDA concentrations were 25 µg/L and monoacetyl-HpDA and diacetyl-HpDA were 
12.5 µg/L. 
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A series dilution was performed in urine with monoacetyl-HDA and diacetyl-HDA. 
Ten samples were used from this dilution series for the analysis (10.144, 5.039, 2.507, 1.247, 
0.621, 0.309, 0.154, 0.076, 0.038, and 0.019 µg/L). All samples were analyzed with the 
integration program or manual integration using the QuanBrowser in Xcalibur. 
 
Standard Curve for Monoacetyl-HDA 
The calibration curve for monoacetyl-HDA included 9 of the 10 points. The 
calibration point corresponding to concentration of 0.038 µg/L was excluded because the 
percent difference of the calculated amount using the linear regression curve exceeded 10%. 
The correlation coefficient for the linear regression of the 9 concentrations was R2 = 0.9998. 
The lowest concentration included in the calibration curve was 0.019 µg/L, which had a 
signal-to-noise ratio of 7.99. Therefore, the limit of quantitation (LOQ) for this method was 
0.02 µg/L (0.13 fmol/µL; 3.15 fmol per 25 µL injection). Since no points below 0.019 µg/L 
were analyzed, the limit of detection (LOD) for this method was estimated to be half of the 
LOQ, i.e., 0.01 µg/L (0.06 fmol/µL; 1.6 fmol per 25 µL injection). The results for 
monoacetyl-HDA analysis of all 10 samples are presented in Table 4. The calibration curve 
for monoacetyl-HDA is presented in Figure 13. 
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Table 4. Results for monoacetyl-HDA analysis. 
Expected 
Amount 
(µg/L) 
Calculated 
Amount 
(µg/L) 
% 
Difference Area IS Area S/N 
Excluded 
Points 
Area 
Ratio 
0.019 0.020 4.93 132223.19 1495026.97 7.99  0.088 
0.038 0.232 511.51 152789.17 1384955.52 12.84 excluded 0.110 
0.076 0.073 -3.90 121064.24 1288523.32 5.31  0.094 
0.154 0.145 -5.42 134902.30 1331098.14 12.17  0.101 
0.309 0.319 3.48 145539.02 1220242.30 8.26  0.119 
0.620 0.647 4.30 186871.24 1221441.87 7.71  0.153 
1.247 1.215 -2.56 251386.66 1188896.55 10.44  0.211 
2.507 2.585 3.10 394277.87 1118995.36 11.37  0.352 
5.039 4.920 -2.36 680037.50 1147428.15 31.64  0.593 
10.144 10.183 0.38 1370738.34 1208526.71 51.02  1.134  
 
Figure 13. Calibration curve for monoacetyl-HDA with monoacetyl-HpDA as the 
internal standard. Nine standard concentrations with a range of 0.019-10.144 µg/L were 
used for this curve. 
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Standard Curve for Diacetyl-HDA 
 The calibration curve for diacetyl-HDA included 6 of the 10 points, excluded were 
the standard concentrations of 0.019, 0.038, 0.076, and 1.247 µg/L. The points 0.019 and 
0.038 µg/L were excluded because the S/N ratio was below 3. The points 0.076 and 1.4247 
µg/L were excluded because the percent difference of the calculated amount using the linear 
regression curve exceeded 10%. The correlation coefficient for the linear regression was R2 = 
0.9997. The lowest concentration included in the calibration curve was 0.154 µg/L, which 
had a signal-to-noise ratio of 3.10. Therefore the LOD for this method was 0.16 µg/L (0.80 
fmol/µL; 19.89 fmol per 25 µL injection). The LOQ for this method was 0.31 µg/L (1.54 
fmol/µL; 38.54 fmol per 25 µL injection) with a S/N ratio of 6.30. The results for diacetyl-
HDA analysis of all 10 samples are presented in Table 5. The calibration curve for diacetyl-
HDA is presented in Figure 14. The LOD and LOQ for monoacetyl-HDA and diacetyl-HDA 
are presented in Table 6. 
 
Table 5. Results for diacetyl-HDA analysis. 
Expected 
Amount 
(µg/L) 
Calculated 
Amount 
(µg/L) 
% 
Difference Area IS Area S/N 
Excluded 
Points 
Area 
Ratio 
0.019 0.044 130.89 14021.79 2448703.66 1.15 excluded 0.006 
0.038 0.048 27.38 13750.47 2230583.24 1.42 excluded 0.006 
0.076 0.107 40.26 24328.49 2100644.04 4.32 excluded 0.012 
0.154 0.156 1.67 36182.67 2247790.01 3.10  0.016 
0.309 0.333 7.80 63865.93 1972161.49 6.30  0.032 
0.620 0.629 1.37 123367.72 2066700.33 10.82  0.060 
1.247 2.803 124.74 497325.37 1911802.42 39.13 excluded 0.260 
2.507 2.405 -4.08 431460.40 1931340.93 30.48  0.223 
5.039 5.126 1.73 913473.87 1925919.85 110.75  0.474 
10.144 10.129 0.15 1760267.69 1881457.53 167.48  0.936 
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Figure 14. Calibration curve for diacetyl-HDA with diacetyl-HpDA as the internal 
standard. Six concentrations with a range of 0.154-10.144 µg/L were used for this curve. 
 
Table 6. LOD and LOQ for monoacetyl-HDA and diacetyl-HDA. 
 Monoacetyl- HDA Diacetyl-HDA 
 LOD LOQ LOD LOQ 
µg/L 0.01 0.02 0.16 0.31 
fmol/µL 0.06 0.13 0.80 1.54 
fmol per 25 µL injection 1.57 3.15 19.89 38.54 
 
CHAPTER IV 
 
DISCUSSION 
 
 
 
In previous scientific studies (Tinnerberg et al. 1995; Maitre et al. 1996; Flack et al. 
2010ab; Gaines et al. 2010), HDA, after derivatization, had been detected in hydrolysed urine 
and plasma samples collected from occupationally exposed workers using GC-MS or LC-MS 
methods. Here, we report a development of an LC-MS method to detect HDI monomer 
metabolites HDA, monoacetyl-HDA, and diacetyl-HDA, as well as isotriamine, a hydrolysis 
product of HDI oligomer isocyanurate. The method is distinguished by the direct 
determination of HDI monomer amines and isocyanurate amine without derivatization. 
LC-MS analysis was performed with positive electrospray ionization because the 
amine and acetyl functional groups present on HDI metabolites ionize efficiently. Early 
efforts included the use of several test columns with poor resolution and separation of the 
analytes. The analytes with the lowest masses (HDA, HpDA, monoacetyl-HDA, monoacetyl-
HpDA) eluted too quickly and, thus, satisfactory separation and detection were not achieved. 
The aqueous phase had to be increased to 95+% to achieve some separation because of the 
high polarity and solubility of the analytes in both water and organic solvents. Separation 
was initially achieved with a C18 Hypurity column (50 x 4.6 mm, 3 µm) that had been 
previously used for analysis of HDI in air and paint samples after derivatization. Better 
separation was achieved with the C18 Hypersil Gold column (150 x 2.1 mm, 3 µm) at a 
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slower flow rate (250 µL/min). This observation led to the development and optimization of 
the LC-MS method described earlier in the Instrumentation section. 
The use of multiple aqueous and organic phases were explored including methanol, 
acetonitrile:methanol, and acetonitrile for the organic phase and formic acid, ammonium 
formate, acetic acid, and ammonium acetate in water for the aqueous phase. The best 
separation, sensitivity, and peak shape was achieved with the combination of 50:50 
acetonitrile:methanol as the organic phase and 0.1% formic acid in water as the aqueous 
phase. Initially, this method was developed using the HPLC ion trap mass spectrometer. At 
high concentrations all analytes (i.e., HDA, HpDA, monoacetyl-HDA, monoacetyl-HpDA, 
diacetyl-HDA, diacetyl-HpDA, and isotriamine) could be detected and separated in both 
water and urine. However, after the analysis of the serial dilutions with all analytes in urine 
using the ion trap, it was clear that the lower concentrations of HDA and isotriamine could 
not be detected in urine. Since the ion trap mass spectrometer was not sensitive enough for 
the analysis of HDA and isotriamine, analysis with a UPLC triple quadrupole mass 
spectrometer was attempted. 
Using the UPLC-triple quadrupole mass spectrometer, the method developed on the 
HPLC-ion trap mass spectrometer was modified to perform analysis for all analytes (i.e., 
HDA, HpDA, monoacetyl-HDA, monoacetyl-HpDA, diacetyl-HDA, diacetyl-HpDA, and 
isotriamine) using a UPLC column. The starting aqueous gradient was raised from 95% to 
98% and the overall time for sample analysis was shortened from 20 to 16 min. After some 
samples of spiked urine were run, it was apparent that the current method or equipment was 
not suitable for analyzing HDA and isotriamine at concentrations lower than 10 µg/L. The 
analysis of HDA and isotriamine proved to be challenging with the current method. 
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Therefore, we focused on obtaining calibration curves for monoacetyl-HDA and        
diacetyl-HDA. 
Our results indicate that the developed LC-MS method is sensitive and specific for 
determination of monoacetyl-HDA and diacetyl-HDA in urine. This method is ready to be 
tested for biological monitoring of workers exposed to HDI. The advantage of this new 
method is the reduced sample preparation time due to elimination of sample extraction and 
derivatization. 
 
Advantages and Limitations 
An improvement of the LC-MS method over the GC-MS method is the reduction in 
time of sample work-up. Our previous research of HDA in urine and blood samples of 
occupationally exposed workers utilizes alkaline hydrolysis and solvent extraction. The 
hydrolysis and extraction of a sample batch (n=40) typically takes 2-3 h. After extraction, the 
samples are derivatized using HFBA or related compounds. Derivation with HFBA normally 
requires 1 h after which samples are dried. Drying times vary by solvent. Dichloromethane, 
the most volatile extraction solvent used, typically takes 45 min to evaporate under nitrogen 
for 6 mL total volume while toluene can take up to 4 hr. The sample work-up procedure can 
take 7-8 h before GC-MS analysis. With the newly developed LC-MS method, the only step 
following alkaline hydrolysis is centrifugal mass filtration. Including hydrolysis, this process 
takes approximately 2 h, hence reducing sample work-up by roughly 6 h. For a high sample 
throughput, the new method could reduce analysis time by days or weeks. 
Eliminating solvent extraction provides a benefit because the potential loss is 
minimized. In the previous reported GC-MS and LC-MS methods, toluene was primarily 
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used as the extraction solvent. As reported by Sakai et al. (2002), toluene has low extraction 
efficiency for TDA isomers, which may be analogous to the efficiency of toluene extraction 
of HDA. In preliminary experiments, toluene extracted <30% of HDA, monoacetyl-HDA, 
and diacetyl-HDA in water. Ethyl acetate and dichloromethane were also tested for their 
extraction efficiencies. Ethyl acetate was similar to toluene and extracted <30% of HDA, 
monoacetyl-HDA, and diacetyl-HDA. Dichloromethane performed much better but only 
extracted ~60% of monoacetyl-HDA and <40% of both HDA and diacetyl-HDA. Our new 
method eliminates solvent extraction, which will significantly reduce sample loss. 
In addition to eliminating extraction, the derivatization step is no longer needed for 
analysis. Derivatization of diacetyl-HDA is more difficult because the substitution of two 
acetyl functional groups for the two amine groups makes it less likely to react completely 
with HFBA and other anhydrides. Derivatization of isotriamine with HFBA and GC-MS 
analysis of the product has not been reported in the published literature. The molecular 
weight of the isotriamine-HFBA derivative is 1014 amu, which is beyond the upper mass 
limit (1000 amu) of most GC-MS equipment. Preliminary tests for analysis of isotriamine-
HFBA using GC-MS were unsuccessful. It seems unlikely that an isotriamine derivative can 
be analyzed using GC-MS and, thus, elimination of derivatization and use of LC-MS may 
prove to be the method of choice. 
Another advantage of the LC-MS method is the reduction in chromatographic 
separation time. The GC-MS methods previously described (Rosenberg et al. 1986; Brorson 
et al. 1990a; Dalene et al. 1994; Tinnerberg et al. 1995; Creely et al. 2006; Pronk et al. 2006; 
Flack et al. 2010a; Gaines et al. 2010) require 30-40 min for analysis of each sample. With 
our LC-MS method, all desired analytes eluted before 7 min. A full analytic cycle for one 
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sample with this method was 16 min. Thus, this new LC-MS method is more efficient with 
faster sample work-up and analysis procedures. 
This study provides the basis for analysis of biological samples (urine, plasma, 
hemoglobin) from workers exposed to HDI and the oligomer isocyanurate in automotive 
spray painting operations. The LC-MS method will greatly reduce sample work-up time and 
chromatographic separation time as well as expand the sample analysis to include HDI 
acetylated biomarkers. Further improvements can be made to the LC-MS method. There is 
greater separation in the chromatographic elution of monoacetyl-HDA and its internal 
standard monoacetyl-HpDA (~3 min) than diacetyl-HDA and diacetyl-HpDA (~0.5 min). In 
LC-MS analysis, it is desirable that the internal standard elutes as closely as possible to the 
analyte. An alternative internal standard for monoacetyl-HpDA could be 13C2-labeled 
monoacetyl-HDA that would have the same structure and differ in mass by 2 amu. 
Commercially available 13C4-labeled acetic anhydride is available and could be used to 
derivatize HDA. 
Currently, we do not have an internal standard that can be utilized for analysis of 
isotriamine. For the other compounds, hepta-aliphatic chains have been used because of 
structure and physico-chemical properties similar to the hexane-carbon chains that 
characterize the analytes. The difference between the analytes and internal standards is one 
CH2 group with a mass difference of 14 amu. A hepta-version of isotriamine would have a 
mass difference of 42 amu. This standard could be synthesized starting with commercially 
available compounds 7-bromoheptan-1-ol and isocyanuric acid. The procedure is outlined in 
Figure 15 and is based on published methods (Ghosh et al. 1994; Nilsen et al. 2007; 
Kunishima et al. 2009). 
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Figure 15. Scheme for synthesis of 1,3,5-tris(6-aminoheptyl)-1,3,5-triazinane-2,4,6-
trione. 
 
 The method demonstrates high sensitivity for both monoacetyl-HDA and diacetyl-
HDA with the limit of detection 0.01 and 0.16 µg/L, respectively. In comparison with a 
recently published GC-MS method for biomarker analysis from HDI monomer exposure, the 
LOD for monoacetyl-HDA is lower with LC-MS (0.01 µg/L) than it is with the GC-MS (0.02 
µg/L) (Flack et al. 2010b). However, the LOD for diacetyl-HDA (0.16 µg/L) is 
approximately ten times higher using LC-MS than it is using GC-MS (0.015 µg/L) (Flack et 
al. 2010b). Table 7 lists the LOD and LOQ for monoacetyl-HDA and diacetyl-HDA using 
the LC-MS method developed in this study and using GC-MS method reported in Flack et al. 
(2010b). The LOD for diacetyl-HDA with the LC-MS can likely be improved by achieving 
better separation for diacetyl-HDA from an unknown urine metabolite peak, which elutes 
within 0.05 min under our analytical conditions. There was little separation achieved of the 
unknown urine metabolite peak from the diacetyl-HDA peak with the set of samples used to 
create the calibration curve. At lower concentrations, the peak appeared as a small shoulder 
on the tailing side of the urine peak and was not identified as an individual peak by the 
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computer software. Manual integration of the peaks was necessary and resulted in an 
unacceptable S/N ratio <3. One option to improve this chromatography is to modify the 
gradient program to hold the initial eluant composition for 1-2 min, around the retention time 
for diacetyl-HDA. Initial attempts at decreasing the rate of the gradient were promising. At 
the 5.5-min mark the program was held isocratic for 2 min and the percent of organic and 
aqueous phases was modified slightly each time. Figure 16 displays the chromatographic 
separation of the urine metabolite peak and diacetyl-HDA with the current method. Figure 17 
displays the improved chromatographic separation of the urine metabolite peak and diacetyl-
HDA peak with the gradient held isocratic for 2 min. 
 
Table 7. Comparison of LOD and LOQ (µg/L) between the LC-MS method developed 
in this studya and the GC-MS method reported in Flack et al. (2010b)b. Flack et al. 
(2010b) used derivatization after base hydrolysis or no treatment. 
 LODa LOQa LODb LOQb LODb LOQb 
   Base Hydrolysis No Treatment 
Monoacetyl-HDA 0.01 0.02 0.022 0.080 0.020 0.070 
Diacetyl-HDA 0.16 0.31 0.050 0.20 0.015 0.050 
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Figure 16. Chromatogram of diacetyl-HDA with the current LC-MS method. The 
gradient was increased from 2% organic to 90% organic from 2-9 min. Separation of 
the two peaks is approximately 0.04 min. 
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Figure 17. Chromatogram of diacetyl-HDA with an isocratic gradient. The gradient 
was held isocratic at 60% aqueous, 40% organic for 2 min (5.5-7.5 min range). 
Separation of the two peaks by approximately 0.08 min was achieved using this 
modification of the LC-MS method gradient. 
 
 Another limitation of this method is that it is only specific for monoacetyl-HDA and 
diacetyl-HDA. The goal of developing this method is to have fast, efficient means of 
analyzing all four desired compounds (i.e., HDA, monoacetyl-HDA, diacetyl-HDA, and 
isotriamine) in a single analytical run., It is particularly important to develop a method for 
analyzing isotriamine since isocyanurate is the most abundant isocyanate in the automotive 
spray painting environment and no method for analysis of isocyanurate metabolites has been 
published.
   41 
Published methods exist for analysis of HDA in urine using GC-MS (Tinnerberg et al. 
1995; Maitre et al. 1996, Gaines et al. 2010). GC-MS analysis for HDA can be performed 
using extraction and derivatization if the LC-MS analysis of HDA cannot be developed. 
However, recent trials using a triple quadrupole mass spectrometer with heated electrospray 
ionization (HESI+) have shown improved sensitivity for HDA and isotriamine.  The HESI+ 
source is held at 300°C and can be far more sensitive than ESI+ because high heat nebulizes 
liquid more efficiently. Thus, more particles are transferred to the mass spectrometer giving 
the machine better sensitivity. This could also improve LODs for monoacetyl-HDA and 
diacetyl-HDA. 
 Extraction of the sample is a possibility if it is deemed that the urine matrix does not 
allow for specific analysis of HDA and isotriamine. The GC-MS methods cited in the 
Introduction section include a simple extraction procedure using a solvent such as toluene or 
dichloromethane. This extraction removes the compound from the urine and the extract can 
be easily concentrated drying under nitrogen. However, some extraction experiments were 
performed with all seven analytes in urine using dichloromethane. HDA and isotriamine 
were not detected. Another possibility is a solid-phase extraction (SPE), which is commonly 
used in drug testing for amines. SPE could be more efficient than solvent extractions in a 
glass vial and would effectively remove most urine metabolites. There are no published 
methods regarding an SPE work-up for isocyanates and isocyanate metabolites. A SPE 
method would also be beneficial to monoacetyl-HDA and diacetyl-HDA because it would 
eliminate almost all urine metabolites and reduce background and interference in the mass 
spectrometer. It would also extend the life of the guard column and the UPLC column by 
reducing the levels of water-soluble metabolites, which build up in the columns over time. 
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This would reduce cost and require less maintenance and cleaning of the LC and MS 
components. The LC-MS method developed for analysis of monoacetyl-HDA and diacetyl-
HDA analytes will make it possible to analyze large quantities of urine samples more 
efficiently with faster sample work-up procedures and a rapid LC gradient program. More 
improvement is needed to include the analysis of HDA and isotriamine. 
 
CHAPTER V 
 
CONCLUSION 
 
 
 
 Biomonitoring of HDI exposure is important because of its widespread use in the 
automotive refinishing industry where exposure may cause occupational asthma and other 
debilitating respiratory and skin effects. The HDI hydrolysis product, HDA, has been 
monitored extensively in urine and blood as a biomarker for HDI exposure. Scientific studies 
have concentrated on biomarkers of exposure to HDI, which comprises less than 1% of 
isocyanates in spray paints and clear coats. Previous studies have indicated that isocyanurate 
comprises the largest component of worker exposure in occupational spray-painting settings. 
Expanding biomonitoring of HDI exposure to include metabolites of isocyanurate can 
increase the array of biomarkers related to overall exposure and contribute to understanding 
the association between exposure and susceptibility to disease. Additionally, most studies 
have not included the acetylated products of HDA, monoacetyl-HDA and diacetyl-HDA. 
These compounds could prove to be important biomarkers of HDI exposure and, are potential 
biomarkers of susceptibility to HDI-induced asthma. The variability in the concentration of 
HDI and isocyanurate biomarkers in urine and blood is an important component in defining 
the role individual genetic differences in metabolism. 
 The LC-MS method developed here is able to detect acetylated metabolites of HDI in 
urine. This method employs SRM monitoring specific for the target analytes monoacetyl-
HDA and diacetyl-HDA using LC-MS with positive ion electrospray ionization. The work- 
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up procedure for urine is simple and results in little or no sample loss. The division of urine 
filtrate and protein concentrate will allow us to determine the fraction of free and conjugated 
analytes in future studies. Currently, our method is not specific and sensitive for analysis of 
HDA and isotriamine at concentrations below 10 µg/L. Recent trials have shown promising 
results for the analysis of HDA and isotriamine using a heated electrospray ionization source 
(HESI+), which nebulizes the liquid particles more efficiently than ambient temperature ESI+. 
Efforts will be directed toward modification of this method to include the analysis of HDA 
and isotriamine in urine. 
 Our new method will allow researchers to quickly and efficiently determine levels of 
acetylated urinary biomarkers in relation to HDI monomer exposure with suitable 
modification may potentially be applied to determine HDA and isotriamine levels in urine. 
Additionally, this method can be developed further to analyze HDI and isocyanurate 
metabolites in blood. When validated, these biomarkers have a potential to allow for better 
evaluation of HDI and isocyanurate exposure and investigation of individual susceptibility to 
adverse health effects due to exposure to these compounds. 
Future research will focus on the improvement of the current method to analyze HDA 
and isotriamine at low concentrations in urine and blood. Our goal will be to apply the LC-
MS method for the analysis of these metabolites in urine and blood samples collected from 
workers occupationally exposed to HDI-based paints and clear coats. Further, after validation 
of these biomarkers (i.e., HDA, monoacetyl-HDA, diacetyl-HDA, and isotriamine) we intend 
to examine the exposure-dose relationship due to inhalation and dermal exposure to HDI and 
isocyanurate. 
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APPENDIX A 
LC-MS METHOD FOR HPLC ION TRAP MASS SPECTROMETER 
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APPENDIX B 
 
LC-MS METHOD FOR UPLC TRIPLE QUADRUPOLE MASS SPECTROMETER 
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APPENDIX C 
 
INTERNAL STANDARDS 
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APPENDIX D 
 
MANUAL INTEGRATION OF MONOACETYL-HDA AND DIACETYL-HDA IN THE 
QUANBROWSER 
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